International Journal of Pharma and Bio Sciences
ijpbs.net
editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com
10.22376/ijpbs.2019.10.1.p1-12
Volume 4 Issue 4
2013 (October - December)
A MOLECULAR DOCKING APPROACH TO STUDY BINDING MOLECULAR INTERACTIONS BETWEEN HERBAL COMPOUND BALANITIN-6 AND PLASMODIUM VIVEX DIHYDROFOLATE REDUCTASE
In this paper, herbal compound Balanitin-6 a diosgenyl saponin, found in the bark and seed of lessThan i greaterThan Balanites aegyptiaca lessThan /i greaterThan has been investigated as potential inhibitor of lessThan i greaterThan Plasmodium vivex lessThan /i greaterThan didydrofolate reductase (PvDHFR) activity. Molecular interaction analysis using Ligplot, Chimera, and PyMol of Balanitin-6/PvDHFR complex have revealed three hydrogen bonds with active site residues Ser58, Ser120, Arg131 and ten hydrophobic interactions in Site1 hydrophilic domin. The minimum binding energy was found to be -21.31Kcal/Mol and the inhibition constant (Ki) value of 237.79 aM which is 10 lessThan sup greaterThan 12 lessThan /sup greaterThan times higher than other Food Drug Administration (FDA) approved drugs. The possible molecular interactions in close proximity to FDA approved drugs have been acknowledged and due to close proximity of Site1 active residues, where it forms part of the substrate-binding cleft, it is likely that displacement of Site1 region will interfere with substrate binding. Hence, Balanitin 6 targeted to Site1 might have sufficient profound effect to inhibit malarial protein PvDHFR activity.
C. SENIYA AND V. VYAS
Malaria, Plasmodium vivex dihydrofolate reductase, molecular docking, Balanitin-6.
698-710